[1]
matta, saksham et al. 2023. COMPARISON BETWEEN RENOPROTECTIVE EFFECTS OF FEBUXOSTAT AND ALLOPURINOL IN CHRONIC KIDNEY DISEASE PATIENTS WITH HYPERURICEMIA. Asian Journal of Pharmaceutical and Clinical Research. 16, 10 (Oct. 2023), 54–58. DOI:https://doi.org/10.22159/ajpcr.2023.v16i10.48016.